Brief: Corbus Pharmaceuticals Q2 Basic EPS USD -1.44
05/08/2025 14:14
Aug 5 (Reuters) - Corbus Pharmaceuticals Holdings Inc CRBP.O: CORBUS PHARMACEUTICALS Q2 NET INCOME USD -17.662 MILLION CORBUS PHARMACEUTICALS Q2 OPERATING EXPENSES USD 19.152 MILLION CORBUS PHARMACEUTICALS Q2 BASIC EPS USD -1.44 Source text: ID:nGNX4vkJTZ Further company coverage: CRBP.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Corbus Pharmaceuticals Holdings
See all newsU.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-PBF Energy, Crown Castle, Definium Therapeutics
U.S. STOCKS ON THE MOVE-AI stocks, energy companies, Johnson & Johnson
U.S. STOCKS ON THE MOVE-US energy stocks, Baldwin, Johnson & Johnson
Corbus gains on weight-loss data for obesity drug in early-stage study